Company / R&D Expense
Bio Green Med Solution, Inc. R&D Expense History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$848.0K
FY2025
5-year range
$848.0K / $18.3M
FY2021-FY2025
Trend
-80.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has declined for 4 consecutive years, from $18M in FY2014 to $848,000 in FY2025.
Based on SEC 10-K filings.
$848,000 in FY2025 with a 10-year CAGR of -23.5%.
Declined from $9M to $848,000 over the past 9 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -23.5%
Key checks
Key Insights
- Bio Green Med Solution, Inc.'s r&d expense has declined for 4 consecutive years.
- In FY2025, r&d expense decreased 80.0% year-over-year.
- Peak r&d expense was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -47.65 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $848.0K | -80.0% |
| FY2017 | $4.2M | -55.3% |
| FY2016 | $9.5M | -23.5% |
| FY2015 | $12.4M | -32.3% |
| FY2014 | $18.3M | +62.1% |
| FY2013 | $11.3M | +71.1% |
| FY2012 | $6.6M | -28.4% |
| FY2011 | $9.2M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026